. . "000166656600003" . . "Citlivost baroreflexu stanoven\u00E1 spektr\u00E1ln\u00ED metodou a variabilita tepov\u00E9 frekvence, mortalita pacient\u016F dva roky po infartu myokardu"@cs . "P(NA4731), Z(MSM 141100004)" . "RIV/00216224:14110/00:00002701" . "Fi\u0161er, Bohumil" . . . "[5EEE8ABFE1C9]" . . "Baroreflex sensitivity determined by spectral method and heart rate variability, and two-years mortality in patients after myocardial infarction." . . "6" . "14110" . . . . "Baroreflex sensitivity determined by spectral method and heart rate variability, and two-years mortality in patients after myocardial infarction."@en . "0862-8408" . "Citlivost baroreflexu stanoven\u00E1 spektr\u00E1ln\u00ED metodou a variabilita tepov\u00E9 frekvence, mortalita pacient\u016F dva roky po infartu myokardu"@cs . "705425" . "RIV/00216224:14110/00:00002701!RIV09-MSM-14110___" . . . "4"^^ . "8"^^ . "L\u00E1brov\u00E1, R\u016F\u017Eena" . "Honz\u00EDkov\u00E1, Nata\u0161a" . . . "4"^^ . "Baroreflex sensitivity determined by spectral method and heart rate variability, and two-years mortality in patients after myocardial infarction." . "49" . "Vliv autonomn\u00ED dysfunkce na mortalitu pacient\u016F po infarktu myokardu byla studov\u00E1na u 162 pacient\u016F (20 zem\u0159elo b\u011Bhem dvou let po IM).Rizikov\u00E1 stratifikace byla hodnocena pro autonomn\u00ED dysfunkci(citlivost baroreflexu, variabilitu tepov\u00E9 frekvence) a pro ejek\u010Dn\u00ED frakci, pozdn\u00ED potenci\u00E1ly a po\u010Det extrasystol za hodinu. Autonomn\u00ED dysfunkce zv\u00FD\u0161ila mortalitu \u0161estkr\u00E1t."@cs . "Baroreflex sensitivity determined by spectral method and heart rate variability, and two-years mortality in patients after myocardial infarction."@en . . "CZ - \u010Cesk\u00E1 republika" . . . . "The impact of an autonomic dysfunction (AD) on mortality in patients after myocardial infarction was evaluated. We examined 162 patients (20 died in two years after myocardial infarction). Baroreflex sensitivity BRS<3ms/mmHg (spectral analysis of spontaneous fluctuations of systolic blood pressure and cardiac intervals) and/or SDNN index<30ms (from 24-hour ECG recording) were taken as markers of AD. The risk stratification was performed according to the number of following standard risk factors (SRF): ejection fraction;40%, positive late potentials and presence of ventricular extrasystoles;10/hour. In 92 patients without SRF, there was no difference in mortality between patients with AD (4%) and without AD (4.5%). In 6 patients with three SRF, mortality was 66.6%. Of 64 patients with one or two SRF, 32 had AD. Mortality was 6.25% in patients without AD and 31.2% in those with AD (p<0.025). AD increased five times the two years mortality in patients with moderate risks." . "Physiological Research" . . . "The impact of an autonomic dysfunction (AD) on mortality in patients after myocardial infarction was evaluated. We examined 162 patients (20 died in two years after myocardial infarction). Baroreflex sensitivity BRS<3ms/mmHg (spectral analysis of spontaneous fluctuations of systolic blood pressure and cardiac intervals) and/or SDNN index<30ms (from 24-hour ECG recording) were taken as markers of AD. The risk stratification was performed according to the number of following standard risk factors (SRF): ejection fraction;40%, positive late potentials and presence of ventricular extrasystoles;10/hour. In 92 patients without SRF, there was no difference in mortality between patients with AD (4%) and without AD (4.5%). In 6 patients with three SRF, mortality was 66.6%. Of 64 patients with one or two SRF, 32 had AD. Mortality was 6.25% in patients without AD and 31.2% in those with AD (p<0.025). AD increased five times the two years mortality in patients with moderate risks."@en . "Semr\u00E1d, Bo\u0159ivoj" . . "Baroreflex sensitivity; spectral analysis; myocardial infarction; cardiac death; risk stratification."@en . .